Literature DB >> 30739959

Synthesis of amorpha-4,11-diene from dihydroartemisinic acid.

Geoffrey Schwertz1,2, Andrea Zanetti1,2, Marllon Nascimento de Oliveira1,2, Mario Andrès Gomez Fernandez1,2, Fabienne Dioury2, Janine Cossy1, Zacharias Amara2.   

Abstract

Amorphadiene is a natural product involved in the biosynthesis of the antimalarial drug artemisinin. A convenient four-step synthesis of amorphadiene, starting from commercially available dihydroartemisinic acid, is reported. The targeted molecule is isolated with an overall yield of 85% on a multi-gram scale in four steps with only one chromatography.

Entities:  

Keywords:  Amorphadiene; Artemisinin; Elimination; Malaria; Microwaves

Year:  2019        PMID: 30739959      PMCID: PMC6346372          DOI: 10.1016/j.tet.2018.12.050

Source DB:  PubMed          Journal:  Tetrahedron        ISSN: 0040-4020            Impact factor:   2.457


Introduction

Amorphadiene (AD) is produced in plants by cyclization of farnesyl-pyrophosphate by the enzyme amorphadiene synthase (ADS) (Scheme 1) [1]. AD is a key intermediate in the biosynthesis of the antimalarial drug artemisinin [1,2]. In this context, the synthesis of AD has been described using a fermentation route (Amyris process) [[2], [3], [4]]. However, AD is not yet commercially available. Herein, we report a short and high-yielding gram-scale synthesis of AD starting from the commercially available dihydroartemisinic acid, 1, which is an intermediate in the Sanofi process to prepare artemisinin [5].
Scheme 1

Semi-synthetic approach for the production of artemisinin (Amyris/Sanofi processes).

Semi-synthetic approach for the production of artemisinin (Amyris/Sanofi processes). With the goal of providing a direct and scalable access to AD from the commercially available natural product dihydroartemisinic acid, 1, a three-step synthetic procedure, relying on the carboxylic acid reduction to the corresponding alcohol 2, followed by an activation/elimination sequence to produce AD, was envisioned (Scheme 2). Bouwmeester et al. described a similar synthetic approach as ours, starting from artemisinic acid, affording AD with an overall yield of 25% [6]. However, only a generic route was reported without detailed procedures, scale, and yield for each individual step.
Scheme 2

Formation of amorphadiene, AD, from dihydroartemisinic acid, 1.

Formation of amorphadiene, AD, from dihydroartemisinic acid, 1.

Results and discussion

Our attempts for the direct reduction of 1 to 2 focused on the use of lithium aluminium hydride (LiAlH4) as a reducing agent. The reaction was first tested using 2.0 equivalents of LiAlH4 in anhydrous THF at 0 °C (Table 1, entry 1) [7]. However, only moderate conversion of 1 was obtained (60%) and alcohol 2 was isolated in only 25% yield after purification. By increasing the amount of LiAlH4 in freshly distilled Et2O and, after stirring at 23 °C for 2 h, alcohol 2 was obtained with a good yield of 85% without purification (Table 1, entry 2). This yield was further improved to 95% by stirring the reaction mixture for 24 h (Table 1, entry 3). Ultimately, we were able to optimize these conditions using 3.0 equivalents of LiAlH4 in non-distilled Et2O at a concentration of 0.29 M (Table 1, entry 4).
Table 1

Reduction of 1 to alcohol 2.

EntryLiAlH4 (equiv)SolventTt [h]ConversionYielda
12.0THF (0.18 M)0 °C1ca. 60%25%
25.0Et2O (0.07 M)0 °C → 23 °C2100%85%
35.0Et2O (0.07 M)b0 °C → 23 °C24100%95%
43.0Et2O (0.29 M)b0 °C → 23 °C16100%95%

Isolated yields.

The reaction was conducted with non-distilled solvent.

Reduction of 1 to alcohol 2. Isolated yields. The reaction was conducted with non-distilled solvent. Different conditions were then evaluated to attempt direct conversion of 2 into AD. Unfortunately, the direct elimination of the hydroxyl group, using either the Burgess reagent [8] or a one-pot selenide strategy, inspired in the Grieco method [9], failed to give satisfying results even on purified 2 (Scheme 3) [10].
Scheme 3

Attempts for the direct synthesis of AD from alcohol 2.

Attempts for the direct synthesis of AD from alcohol 2. Alternatively, we considered the activation of the alcohol followed by an elimination. Alcohol 2 was quantitatively converted to its corresponding mesylate 3 (MsCl, 1.1 equiv; Et3N, 1.5 equiv; in anhydrous CH2Cl2, 1 M) (Scheme 4) [11]. Bouwmeester et al. reported the same transformation of 2 to 3 using pyridine as solvent and base, which however, required purification by column chromatography to isolate pure mesylate 3 [6]. We replaced pyridine with dichloromethane as solvent and used only 1.5 equivalents of base, which afforded pure 3 without further purification.
Scheme 4

Transformation of alcohol 2 to the corresponding mesylate 3.

Transformation of alcohol 2 to the corresponding mesylate 3. The elimination of the leaving group and formation of the CC double bond turned out to be more challenging than anticipated. Several conditions were attempted based on related literature procedures (Table 2) [[12], [13], [14]]. As the direct elimination of the mesylate group failed to give satisfying results (Table 2, entry 1), 3 was treated with sodium iodide (NaI, 5.0 equiv) and 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU, 3.0 equiv) in a one-pot reaction, upon which AD was isolated, after column chromatography, in 35% yield (Table 2, entry 2). Alternatively, DBU was added only after completion of the Finkelstein reaction using NaI (2.0–10.0 equiv) but yields in AD remained moderate (30–40%; Table 2, entries 3–5).
Table 2

Primary screening experiments for the elimination step.

EntryBase (equiv)Additive (equiv)“steps”SolventTt [h]ConversionYield
1DBU (3.0)1THFreflux200%
2DBU (3.0)NaI (5.0)1DMF80 °C → 23 °C48100%35%
3DBU (3.0)NaI (2.0)2DME60 °C → reflux5 then 3100%30%
4DBU (5.0)NaI (5.0)2AcetoneReflux2.5 then 13100%40%
5DBU (5.0)NaI (10.0)2AcetoneReflux13100%30%
THF65 °C3.5
Primary screening experiments for the elimination step. As the one-pot procedure was not high yielding, another method used by Baran et al. on a similar scaffold as 3, [15] consisting of isolating the iodo intermediate 4, after reacting 3 with NaI prior to the addition of base was realized (Scheme 5). The substitution of the mesylate moiety by an iodine proceeded well, affording 4 in yields to 97%.
Scheme 5

Conversion of mesylate 3 into the iodinated intermediate 4.

Conversion of mesylate 3 into the iodinated intermediate 4. After isolation, the iodo-compound 4 was reacted with DBU (5.0 equiv) in boiling acetone and AD was isolated in 45% yield (Table 3, entry 1). It is worth noting that 4-hydroxy-4-methylpentan-2-one was also isolated from this reaction, which presumably indicates that a self-condensation of acetone occurred and thus, acetone was not considered as a relevant solvent to carry out this transformation. In THF, a longer reaction time (24 h instead of 5 h) was required to achieve full conversion of 4 (Table 3, entry 2) but the yield in AD remained modest (45%). With these results in hand, we postulated that DBU could promote undesirable side reactions and we decided to use alternative bases. No conversion was observed with Et3N (5.0 equiv) (Table 3, entry 3), whereas a moderate conversion was recorded with 5.0 equivalents of t-BuOK after 40 h at 65 °C (55%) (Table 3, entry 4). This result was improved by using microwave irradiation and gratifyingly, a complete conversion of 4 was obtained after 1 h producing AD in 89% yield (Table 1, entry 5). Reducing the amount of t-BuOK to 3.0 equiv did not give full conversion of 4 after 1 h in THF (Table 3, entry 6). By using a freshly prepared solution of t-BuOK in THF (1 M), the excess of base was reduced to 1.3 equivalents and the reaction time to 0.5 h, affording 1 in an excellent yield of 96% (Table 3, entry 8). More importantly, it allowed us to increase the concentration in 4 to 0.75 M, which also enabled to scale-up the reaction to 4 g of 4 per batch using a standard 20 mL sealed tube.
Table 3

Optimization of the conditions for the elimination step.

EntryBase (equiv)Solvent[C]T [°C]Time [h]ConversionYield
1DBU (5.0)Acetone0.15 MReflux5100%45%a
2DBU (5.0)THF0.15 M6524100%45%a
3Et3N (5.0)THF0.15 M65400%
4t-BuOK (5.0)THF0.15 M654055%47%b
5t-BuOK (5.0)THF0.15 M65 (μW)c1100%89%a
6t-BuOK (3.0)THF0.15 M65 (μW)155%47%b
7t-BuOK (6.7) (1 M in THF)0.15 M65 (μW)0.5100%90%b
8t-BuOK (1.3) (1 M in THF)0.75 M65 (μW)0.5100%96%a
9t-BuOK (5.0)t-BuOH0.15 M65550%48%b
10t-BuOK (5.0)t-BuOH0.15 M905100%86%b
11t-BuOK (2.0)t-BuOH1.50 M903.5100%63%a

Isolated yield.

Estimated yield based on the GC/MS chromatogram of crude product.

μW = microwave irradiation.

Optimization of the conditions for the elimination step. Isolated yield. Estimated yield based on the GC/MS chromatogram of crude product. μW = microwave irradiation. Because thermal heating is usually preferred over microwave-assisted reaction for large scale synthesis, we also investigated the preparation of AD using conventional heating. A moderate conversion (50%) of 4 was achieved when the reaction was performed in tert-butanol (t-BuOH) at 65 °C (Table 3, entry 9), whereas the iodo intermediate 4 was fully converted to AD when the reaction was carried out in boiling t-BuOH (Table 3, entry 10). Ultimately, we were able to perform the elimination with only 2.0 equivalents of t-BuOK (on a 6.5 g scale) and to isolate AD in 63% yield (Table 3, entry 11). We found that, in this case, 10% of the alcohol 2 was formed along with other unidentified side products (estimated yield based on 1H NMR).

Conclusion

In summary, a screening of conditions allowed us to secure a straightforward access to the important terpene, amorphadiene (AD), from commercially available dihydroartemisinic acid 1 (Scheme 6). The most challenging step was the elimination step, which required considerable optimization. Eventually, 1.3 equiv of t-BuOK (1 M in THF) were sufficient to achieve full conversion of 4 in 0.5 h and to produce AD in 96% yield. Alternatively, we also developed a thermal approach in boiling t-BuOH affording AD in 63% yield. It is noteworthy to mention that alcohol 2 could be transformed in one step to its corresponding bromo derivative 5 by employing an Appel bromination (see Experimental Section) [16], however, a lower yield (35%) was obtained for the elimination step.
Scheme 6

Synthesis of amorphadiene, AD, from dihydroartemisinic acid, 1.

Synthesis of amorphadiene, AD, from dihydroartemisinic acid, 1. A reliable and straightforward multi-gram scale synthesis of amorphadiene from dihydroartemisinic acid has been established with an overall yield of 85%. This will enable future scale-up and access to this key molecule for studying its transformation into artemisinic acid and artemisinin derivatives.

Experimental section

General information

Reagents (Aldrich) were purchased as reagent grade and used without further purification. Reactions in the absence of air and moisture were performed in oven-dried glassware under Ar atmosphere. Flash column chromatography was performed using SiO2 (60 Å, 230–400 mesh, particle size 0.040–0.063 mm, Merck) at 23 °C with a head pressure of 0.0–0.5 bar. The solvent compositions are reported individually in parentheses. Analytical thin layer chromatography (TLC) was performed on aluminium sheets coated with silica gel 60 F254 (Merck, Macherey-Nagel) or with silica gel 60 RP-18 F254s (Merck, Macherey-Nagel). Visualization was achieved using an alkaline aqueous solution of potassium permanganate (KMnO4). Evaporation in vacuo was performed at 25–35 °C and 900–10 mbar. Reported yields refer to spectroscopically and chromatographically pure compounds that were dried under high vacuum (0.1–0.05 mbar) before analytical characterization. 1H and 13C nuclear magnetic resonance (NMR) spectra were recorded on a Bruker AV 400 spectrometer at 400 MHz (1H) and 101 MHz (13C). Chemical shifts δ are reported in ppm upfield using the residual deuterated solvent signals as an internal reference (CDCl3: δH = 7.26 ppm, δC = 77.16 ppm). For 1H NMR, coupling constants J are given in Hz and the resonance multiplicity is described as s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), and br (broad). All spectra were recorded at 298 K. Infrared (IR) spectra were recorded on a Bruker Tensor 27 FT-IR spectrometer and are reported as wavenumbers (cm−1). High-resolution mass spectrometry (HRMS) was performed by the Laboratoire de Spectrométrie de Masse from Sorbonne Université, Paris. Gas Chromatography coupled to Mass Spectrometry (GC/MS) analysis was performed on a Shimadzu GCMS-QP2010S using an electronic impact (EI) spectrometer. Low-resolution mass spectra (LRMS) result from ionization by electronic impact (EI-LRMS). The abundance indicated for each mass number (m/z values) is given in percentage relative to the strongest peak of 100% abundance (base peak). Melting points were determined using a Büchi melting point apparatus in open capillaries. Nomenclature follows the suggestions proposed by the software ChemDraw Professional 2016.

Synthesis of amorpha-4,11-diene (AD)

(R)-2-((1R,4R,4aS,8aS)-4,7-Dimethyl-1,2,3,4,4a,5,6,8a-octahydronaphthalen-1-yl)propan-1-ol (2)

A suspension of LiAlH4 (12.2 g, 321.5 mmol) in Et2O (120 mL) was cooled below 0 °C with an ice/sodium chloride/water bath and treated over 1.5 h with a solution of dihydroartemisinic acid (1) (25.0 g, 105.78 mmol) in Et2O (250 mL) while maintaining the internal temperature below 7 °C. The mixture was maintained in the cold bath, allowed to warm up to 23 °C, stirred for 16 h, cooled below 0 °C, and treated dropwise with H2O (12.5 mL; 1.0 mL/g of LiAlH4) while maintaining the internal temperature below 5 °C. The mixture was stirred at 5 °C for 20 min, treated carefully with a 15% NaOH solution in H2O (12.5 mL; 1.0 mL/g of LiAlH4), stirred for 10 min at 5 °C, and treated with H2O (37.0 mL; 3.0 mL/g of LiAlH4) while maintaining the internal temperature below 5 °C. Anhydrous MgSO4 was added to absorb the remaining water and the mixture was filtered. The filtrate was evaporated to afford 2 (22.40 g, 95%) as a white solid. m.p. 83.9–84.3 °C; Rf = 0.22 (SiO2; petroleum ether/EtOAc 95:05; KMnO4); [α]D20 = −8.8° (c 1.04, CHCl3); 1H NMR (400 MHz, CDCl3): δ = 5.21 (br s, 1H), 3.75 (m, 1H), 3.52 (m, 1H), 2.47 (br s, 1H), 2.08–1.72 (m, 3H), 1.69–1.57 (m, 3H), 1.61 (s, 3H), 1.53 (m, 1H), 1.41 (m, 1H), 1.30–1.14 (m, 2H), 1.00 (d, J = 6.8 Hz, 3H), 1.08–0.88 (m, 2H), 0.86 ppm (d, J = 6.4 Hz, 3H), OH signal too weak to be observed; 13C NMR (101 MHz, CDCl3): δ = 135.3, 120.8, 67.0, 42.8, 42.2, 37.7, 36.8, 35.8, 27.8, 26.8, 26.5, 26.0, 24.0, 20.0, 15.1 ppm; IR (ATR):  = 3335, 3328, 2920, 2865, 1467, 1451, 1432, 1370, 1025, 991, 955 cm−1; HR-ESI-MS: m/z: 245.1875 ([M + Na]+, calcd for C15H26ONa+: 245.1876); GC/MS: m/z (%): 222 (11, [M]+), 191 (14, [M – CH3O]), 163 (100, [M – C3H7O]+), 149 (10), 135 (15), 121 (25), 107 (36), 105 (14). Analytical data correspond to the literature [17].

(R)-2-((1R,4R,4aS,8aS)-4,7-Dimethyl-1,2,3,4,4a,5,6,8a-octahydronaphthalen-1-yl)propyl methanesulfonate (3)

A solution of 2 (18.89 g, 85.0 mmol) in anhydrous CH2Cl2 (85 mL) was cooled to 0 °C, treated with Et3N (18.4 mL, 127.5 mmol), stirred for 5 min at 0 °C, and treated dropwise with MsCl (7.6 mL, 93.5 mmol) leading to a white precipitate. The mixture was stirred at 23 °C for 2.5 h and diluted with CH2Cl2 (40 mL). The organic layer was washed with 1 N HCl (2 × 20 mL), dried over MgSO4, filtered, and evaporated to afford mesylate 3 (25.64 g, quant.) as a white crystalline solid. m.p. 71.7–73.5 °C; Rf = 0.24 (SiO2; petroleum ether/EtOAc 95:05; KMnO4); [α]D20 = −9.8° (c 1.02, CHCl3); 1H NMR (400 MHz, CDCl3): δ = 5.14 (br s, 1H), 4.29 (dd, J = 9.5, 3.2 Hz, 1H), 4.12 (dd, J = 9.5, 6.2 Hz, 1H), 3.00 (s, 3H), 2.47 (br s, 1H), 2.00–1.72 (m, 4H), 1.69–1.48 (m, 3H), 1.63 (s, 3H), 1.40 (m, 1H), 1.31–1.16 (m, 2H), 1.04 (d, J = 6.8 Hz, 3H), 1.02–0.87 (m, 2H), 0.86 ppm (d, J = 6.5 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ = 135.9, 120.0, 74.1, 42.5, 42.0, 37.4, 37.3, 35.5, 34.6, 27.7, 26.8, 26.3, 25.9, 24.0, 19.8, 15.2 ppm; IR (ATR):  = 2911, 2868, 1449, 1353, 1175, 1110, 953 cm−1; HR-ESI-MS: m/z: 323.1650 ([M + Na]+, calcd for C16H28O3SNa+: 323.1651); GC/MS: m/z (%): 300 (11, [M]+), 163 (100, [M – C4H9O3S]+), 147 (17), 133 (10), 121 (29), 119 (19), 107 (31), 105 (20).

(1R,4R,4aS,8aS)-1-((R)-1-Iodopropan-2-yl)-4,7-dimethyl-1,2,3,4,4a,5,6,8a-octahydronaphthalene (4)

A solution of mesylate 3 (12.03 g, 40.0 mmol) in acetone (80 mL) was treated with NaI (18.0 g, 120.1 mmol), stirred at 70 °C for 0.5 h, cooled to 23 °C, diluted with Et2O (100 mL) and H2O (50 mL). The two layers were separated and the aqueous layer was extracted with Et2O (6 × 50 mL). The combined organic layers were washed twice with a Na2S2O3 sat. aqueous solution (100 + 50 mL), dried over MgSO4, filtered, and evaporated to afford 4 (12.33 g, 93%) as a light yellow oil that crystallizes upon cooling in a freezer. Rf = 0.70 (SiO2; hexane; KMnO4); [α]D20 = −32.0° (c 1.02, CHCl3); 1H NMR (400 MHz, CDCl3): δ = 5.17 (br s, 1H), 3.44 (dd, J = 9.7, 2.5 Hz, 1H), 3.30 (dd, J = 9.7, 5.4 Hz, 1H), 2.49 (br s, 1H), 2.03–1.84 (m, 2H), 1.79 (m, 1H), 1.64 (m, 1H), 1.62 (s, 3H), 1.59–1.48 (m, 2H), 1.41 (m, 1H), 1.33–1.10 (m, 3H), 0.99 (d, J = 6.4 Hz, 3H), 0.97–0.89 (m, 2H), 0.87 ppm (d, J = 6.5 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ = 135.8, 121.1, 46.0, 42.1, 37.7, 35.6, 34.8, 27.7, 26.8, 26.1, 25.9, 24.0, 20.2, 19.9, 19.0 ppm; IR (ATR):  = 2906, 2867, 1447, 1433, 1377, 1303, 1291, 1254, 1227, 1191, 1171, 1159, 1110, 1031, 990, 957, 942, 924 cm−1; HR-ESI-MS: molecule not ionized in ESI; GC/MS: m/z (%): 332 (4, [M]+), 163 (100, [M – C3H6I]+), 121 (19), 107 (25), 105 (7).

(1R,4R,4aS,8aS)-1-((R)-1-Bromopropan-2-yl)-4,7-dimethyl-1,2,3,4,4a,5,6,8a-octahydronaphthalene (5)

A solution of 2 (100 mg, 0.45 mmol) in CH2Cl2 (2.5 mL) was treated with PPh3 (236 mg, 0.90 mmol), cooled to 0 °C, treated with CBr4 (375 mg, 1.13 mmol), stirred at 0 °C for 1 h, and evaporated. The crude was absorbed on SiO2 and column chromatography (SiO2 pre-treated with hexane/Et3N 99:01; hexane) gave 5 (128 mg, quant.) as a colorless oil. Rf = 0.60 (SiO2; hexane; KMnO4); [α]D20 = −16.1° (c 0.94, CHCl3); 1H NMR (400 MHz, CDCl3): δ = 5.17 (br s, 1H), 3.61 (dd, J = 9.9, 2.6 Hz, 1H), 3.49 (dd, J = 9.9, 5.6 Hz, 1H), 2.49 (br s, 1H), 2.02–1.74 (m, 4H), 1.70–1.48 (m, 3H), 1.63 (s, 3H), 1.42 (m, 1H), 1.35–1.18 (m, 2H), 1.05 (d, J = 6.5 Hz, 3H), 1.03–0.90 (m, 2H), 0.87 ppm (d, J = 6.5 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ = 135.7, 120.7, 44.2, 42.5, 42.1, 37.6, 35.8, 35.6, 27.7, 26.8, 26.1, 25.9, 24.0, 19.9, 17.0 ppm; IR (ATR):  = 2907, 2869, 1447, 1435, 1379, 1334, 1306, 1290, 1261, 1236, 1218, 1185, 1159, 1140, 1110, 1075, 1037, 991, 958, 942, 925 cm−1; HR-ESI-MS: molecule not ionized in ESI; GC/MS: m/z (%): 286 (4, [M]+), 284 (4, [M]+), 163 (100, [M – C3H6Br]+), 121 (18), 107 (22), 105 (5).

(1R,4R,4aS,8aR)-4,7-Dimethyl-1-(prop-1-en-2-yl)-1,2,3,4,4a,5,6,8a-octahydronaphthalene (amorpha-4,11-diene, AD)

Microwave-assisted approach

Iodo derivative 4 (11.85 g, 35.7 mmol) was treated with t-BuOK (1 M in THF) (46.4 mL, 46.4 mmol), stirred at 65 °C in a microwave oven for 30 min, diluted with Et2O (150 mL) and H2O (150 mL). The two layers were separated and the aqueous layer was extracted with Et2O (4 × 75 mL). The combined organic layers were washed brine, dried over MgSO4, filtered, and evaporated. Column chromatography (SiO2; hexane) gave AD (7.03 g, 96%) as a colorless oil.

Thermal approach

A solution of iodo derivative 4 (6.46 g, 19.43 mmol) in melted t-BuOH (13 mL) was treated with t-BuOK (4.4 g, 39.2 mmol), stirred at reflux for 3.5 h, diluted with Et2O (60 mL) and H2O (60 mL). The two layers were separated and the aqueous layer was further extracted with Et2O (4 × 30 mL). The combined organic layers were dried over MgSO4, filtered, and evaporated. Column chromatography (SiO2; cyclohexane) gave AD (2.52 g, 63%) as a colorless oil. Rf = 0.77 (SiO2; hexane; KMnO4); Rf = 0.34 (RP-18; MeOH; KMnO4); [α]D20 = −13.9° (c 1.00, CHCl3) ([18]: [α]D20 = −14.0° (c 0.4, CHCl3)); 1H NMR (400 MHz, CDCl3): δ = 5.06 (br s, 1H), 4.87 (br s, 1H), 4.64 (br s, 1H), 2.55 (br s, 1H), 2.06–1.83 (m, 3H), 1.77 (m, 1H), 1.74 (s, 3H), 1.67 (dq, J = 12.9, 3.5 Hz, 1H), 1.60 (s, 3H), 1.59–1.46 (m, 2H), 1.40 (m, 1H), 1.35–1.18 (m, 2H), 0.98 (qd, J = 12.8, 3.4 Hz, 1H), 0.89 ppm (d, J = 6.4 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ = 148.5, 135.1, 121.3, 110.2, 48.1, 42.3, 38.1, 35.9, 28.3, 26.9, 26.5, 26.3, 24.1, 23.1, 20.3 ppm; IR (ATR):  = 2918, 2866, 1643, 1446, 1376, 1240, 1173, 1139, 1108, 993, 968, 936 cm−1; HR-ESI-MS: molecule not ionized in ESI; GC/MS: m/z (%): 204 (45, [M]+), 189 (73, [M – CH3]+), 119 (100). Analytical data correspond to the literature [18].
  11 in total

Review 1.  The biosynthesis of artemisinin (Qinghaosu) and the phytochemistry of Artemisia annua L. (Qinghao).

Authors:  Geoffrey D Brown
Journal:  Molecules       Date:  2010-10-28       Impact factor: 4.411

2.  Intramolecular cyclobutadiene cycloaddition/cyclopropanation/thermal rearrangement: an effective strategy for the asymmetric syntheses of pleocarpenene and pleocarpenone.

Authors:  Michael J Williams; Holly L Deak; Marc L Snapper
Journal:  J Am Chem Soc       Date:  2007-01-24       Impact factor: 15.419

3.  Amorpha-4,11-diene synthase catalyses the first probable step in artemisinin biosynthesis.

Authors:  H J Bouwmeester; T E Wallaart; M H Janssen; B van Loo; B J Jansen; M A Posthumus; C O Schmidt; J W De Kraker; W A König; M C Franssen
Journal:  Phytochemistry       Date:  1999-11       Impact factor: 4.072

4.  Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin.

Authors:  Patrick J Westfall; Douglas J Pitera; Jacob R Lenihan; Diana Eng; Frank X Woolard; Rika Regentin; Tizita Horning; Hiroko Tsuruta; David J Melis; Andrew Owens; Scott Fickes; Don Diola; Kirsten R Benjamin; Jay D Keasling; Michael D Leavell; Derek J McPhee; Neil S Renninger; Jack D Newman; Chris J Paddon
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-12       Impact factor: 11.205

5.  Scalable Total Syntheses of (-)-Hapalindole U and (+)-Ambiguine H.

Authors:  Thomas J Maimone; Yoshihiro Ishihara; Phil S Baran
Journal:  Tetrahedron       Date:  2015-05-02       Impact factor: 2.457

6.  Vicinal stereocontrol during nucleophilic addition to arene chromium tricarbonyl complexes: formal synthesis of (+/-)-erythro Juvabione.

Authors:  Anthony J Pearson; Harinandini Paramahamsan; James D Dudones
Journal:  Org Lett       Date:  2004-06-24       Impact factor: 6.005

7.  Syntheses of tricyclic pyrones and pyridinones and protection of Abeta-peptide induced MC65 neuronal cell death.

Authors:  Sandeep Rana; Hyun-Seok Hong; Lydia Barrigan; Lee-Way Jin; Duy H Hua
Journal:  Bioorg Med Chem Lett       Date:  2008-12-24       Impact factor: 2.823

8.  Total syntheses of (-)-alpha-kainic acid and (+)-alpha-allokainic acid via stereoselective C-H insertion and efficient 3,4-stereocontrol.

Authors:  Young Chun Jung; Cheol Hwan Yoon; Edward Turos; Kyung Soo Yoo; Kyung Woon Jung
Journal:  J Org Chem       Date:  2007-11-29       Impact factor: 4.354

9.  High-level semi-synthetic production of the potent antimalarial artemisinin.

Authors:  C J Paddon; P J Westfall; D J Pitera; K Benjamin; K Fisher; D McPhee; M D Leavell; A Tai; A Main; D Eng; D R Polichuk; K H Teoh; D W Reed; T Treynor; J Lenihan; M Fleck; S Bajad; G Dang; D Dengrove; D Diola; G Dorin; K W Ellens; S Fickes; J Galazzo; S P Gaucher; T Geistlinger; R Henry; M Hepp; T Horning; T Iqbal; H Jiang; L Kizer; B Lieu; D Melis; N Moss; R Regentin; S Secrest; H Tsuruta; R Vazquez; L F Westblade; L Xu; M Yu; Y Zhang; L Zhao; J Lievense; P S Covello; J D Keasling; K K Reiling; N S Renninger; J D Newman
Journal:  Nature       Date:  2013-04-10       Impact factor: 49.962

Review 10.  Approaches and Recent Developments for the Commercial Production of Semi-synthetic Artemisinin.

Authors:  Stephanie H Kung; Sean Lund; Abhishek Murarka; Derek McPhee; Chris J Paddon
Journal:  Front Plant Sci       Date:  2018-01-31       Impact factor: 5.753

View more
  2 in total

1.  Chemo- and Diastereoselective Hydrosilylation of Amorphadiene toward the Synthesis of Artemisinin.

Authors:  Geoffrey Schwertz; Andrea Zanetti; Marllon Nascimento de Oliveira; Mario Andrés Gomez Fernandez; Zacharias Amara; Janine Cossy
Journal:  J Org Chem       Date:  2020-07-09       Impact factor: 4.354

2.  Synthesis of [3,3-2H2]-Dihydroartemisinic Acid to Measure the Rate of Nonenzymatic Conversion of Dihydroartemisinic Acid to Artemisinin.

Authors:  Kaitlyn Varela; Hadi D Arman; Francis K Yoshimoto
Journal:  J Nat Prod       Date:  2019-12-20       Impact factor: 4.050

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.